Head-to-head · WeighScore
Candor Rx vs Center for Medical Weight Loss (CMWL)
By GLP-1 ScorecardUpdated
Score comparison
Candor Rx has the higher recorded score — 74.8/100 to 66.9/100.
Candor Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Candor Rx (candorrx.com) is a GLP-1 telehealth service offering compounded semaglutide and tirzepatide with flat, dose-independent pricing marketed as '$95/month, any dose, forever.'
Before you choose
Before comparing the headline prices, the Candor Rx review and the Center for Medical Weight Loss (CMWL) review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Candor Rx vs CoraDoc and Center for Medical Weight Loss (CMWL) vs CoreAge Rx compare each of them with another graded program, and the list of alternatives to Candor Rx ranks the programs closest to Candor Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Candor Rx | Center for Medical Weight Loss (CMWL) |
|---|---|---|
| WeighScore | 74.8/100 | 66.9/100 |
| Grade | C | C |
| Site position | #62 | #187 |
| Semaglutide | $99/mo (all doses, compounded) | $99/mo on monthly billing; $816 billed yearly at the $68/mo equivalent |
| Tirzepatide | $149/mo (all doses, compounded) | $149/mo on monthly billing; $1,416 billed yearly at the $118/mo equivalent |
| Coverage | Coverage not published | Confirm eligibility for the selected treatment |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
- Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
- Medication ships in about 48 hours and you can cancel anytime
- Simple, transparent GLP-1 focus with pricing shown up front before signup
What to consider
- Prescribing medical group and compounding pharmacy are not named on the site
- States of operation are not published; confirm eligibility during intake
- No LegitScript certification is displayed
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Strengths
- Product pages show separate term totals and renewal intervals
- Refund policy distinguishes ineligibility from cancellation after submission for review
What to consider
- Lowest advertised monthly equivalents require annual payment
- Two-month supply plans renew every seven weeks
- Ask which dispensing pharmacy and refund terms apply to the selected order
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.